David Hochman

David Hochman

Directeur Général chez ORCHESTRA BIOMED HOLDINGS, INC.

Fortune : 6 M $ au 31/05/2026

50 ans
Health Technology
Finance
Health Services

Profil

David P.
Hochman
is the founder of OPKO Biologics Ltd. (2001), Prescient Medical, Inc. (2004), Caliber Therapeutics LLC (2009), FreeHold Surgical LLC (2011), BackBeat Medical LLC (2011), Corbus Pharmaceuticals Holdings, Inc. (2013), Orchestra BioMed, Inc. (2018), and Orchestra Biomed Holdings, Inc. (2020).
Titles held at these companies included Director at OPKO Biologics Ltd. (2005–2007), Director at Caliber Therapeutics LLC (2009–2018), Director at FreeHold Surgical LLC (2011–2018), Director at BackBeat Medical LLC (2018), Director at Corbus Pharmaceuticals Holdings, Inc. (2013–2020), Chairman & Chief Executive Officer at Orchestra BioMed, Inc. (2018–present), and Chairman & Chief Executive Officer at Orchestra Biomed Holdings, Inc. (2020–present).
Current jobs include Chairman at Motus G.I.
Medical Technologies Ltd. (2011–present), Director at Corbus Pharmaceuticals, Inc., Director at Aids Action Foundation, and President & Director at Mollie Parnis Livingston Foundation, Inc.Former jobs include Chief Executive Officer at Spencer Trask Edison Partners LLC (1997–2006), Vice Chairman at Naked Brand Group, Inc. (2014–2017), Chairman at Vital Access Corp.
(2008–2017), Director at Orchestra Therapeutics, Inc., Managing Director at Augment Securities, Inc. (2005), Director at Journey Health, Inc. (Virginia) (2013–2018), Director at Citizens Committee for New York City (1999–2019), Director at Adgero Biopharmaceuticals Holdings, Inc. (2015–2020), Independent Director at Motus GI Holdings, Inc. (2023), Advisor at Idera Pharmaceuticals, Inc., Advisor at Health Dialog Services Corp., Managing Partner at Orchestra Medical Ventures LLC, and President at Accelerated Technologies, Inc. (Texas) (2009–2019).
Education includes undergraduate degree from the University of Michigan, conferred in 1997.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
10/06/2026 1 506 085 ( 2,79% ) 6 M $ 31/05/2026

Postes actifs de David Hochman

SociétésPosteDébut
ORCHESTRA BIOMED HOLDINGS, INC. Directeur Général 25/05/2020
Directeur/Membre du Conseil -
Directeur Général 01/05/2018
Président 01/09/2011
Mollie Parnis Livingston Foundation, Inc.
President -
Directeur/Membre du Conseil -

Anciens postes connus de David Hochman

SociétésPosteFin
MOTUS GI HOLDINGS, INC. Président 13/04/2023
CORBUS PHARMACEUTICALS HOLDINGS, INC. Fondateur 11/09/2020
Directeur/Membre du Conseil 01/01/2020
░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░░ ░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de David Hochman

Formation de David Hochman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

81

Relations au 1er degré

26

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées26

Finance

Health Technology

Health Services

Finance

Distribution Services

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Health Services

Consumer Services

Finance

Health Technology

Producer Manufacturing

Spencer Trask Edison Partners LLC

Health Technology

Electronic Technology

Commercial Services

Mollie Parnis Livingston Foundation, Inc.

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. David Hochman
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT